DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
GWP42006 is an investigational drug.
There have been 4 clinical trials for GWP42006. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2019.
The most common disease conditions in clinical trials are Seizures, Child Development Disorders, Pervasive, and Autistic Disorder. The leading clinical trial sponsors are GW Research Ltd and [disabled in preview].
There are two hundred and seventy-one US patents protecting this investigational drug and one international patent.
Recent Clinical Trials for GWP42006
|Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder||GW Research Ltd||Phase 2|
|A Study of GWP42006 in People With Focal Seizures - Part B||GW Research Ltd||Phase 2|
|A Study of GWP42006 in People With Focal Seizures - Part A||GW Research Ltd||Phase 2|
Top disease conditions for GWP42006
Top clinical trial sponsors for GWP42006
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|GWP42006||Get Started Free||Pharmaceutical formulations||GW Pharma Limited (Cambridge, GB)||Get Started Free|
|GWP42006||Get Started Free||Pre-spray emulsions and powders containing non-polar compounds||Virun, Inc. (Pomona, CA)||Get Started Free|
|GWP42006||Get Started Free||Lipid nanoparticle compositions and methods as carriers of cannabinoids in standardized precision-metered dosage forms||NANOSPHERE HEALTH SCIENCES, LLC (Greenwood Village, CO)||Get Started Free|
|GWP42006||Get Started Free||Methods and compositions for treating symptoms of diseases related to imbalance of essential fatty acids||BODYBIO INC. (Millville, NJ)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|GWP42006||Australia||AU2002231970||2021-02-14||Get Started Free|
|GWP42006||Canada||CA2438097||2021-02-14||Get Started Free|
|GWP42006||Canada||CA2533400||2021-02-14||Get Started Free|
|GWP42006||China||CN1886117||2021-02-14||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|